TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/28/2022
Back to search
Official data from USPTO
EYEGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
10/28/2022
Trademark type
Word
Nice classes
16, 42
Filing date
12/01/2008
Registration date
08/24/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/11/2019
Last transaction
12/11/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/01/2007
First use in commerce
03/01/2007
Drawing code
4
Owner type
99
Owner location
Bethesda, MD, US
Examiner
LOTT, MAUREEN DALL
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Representatives
Angela Y. Dai HHS Office Of The General Counsel
Technical classification
Nice Classes
Class 16Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
printed educational materials for physicianshealth care providerspatients in printed formatbrochures and postersfeaturing information on research and clinical trials to study the genetic causes of ocular diseases
Class 42
Research on the subject of the genetic causes of ocular diseases; providing websites featuring medical research information for a national ophthalmic disease genotyping network; providing websites featuring information in the nature of a repository of genetic medical research information; and providing websites featuring medical research informationinformation on clinical trials to study the genetic causes of ocular diseases
Publications
History of USPTO decisions and trademark events.
37 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/28/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/28/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/11/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/11/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/11/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/11/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
10/28/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/24/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/26/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/26/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/26/2016
E815
TEAS SECTION 8 & 15 RECEIVED
07/20/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2010
PUBO
PUBLISHED FOR OPPOSITION
06/08/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/30/2010
ALIE
ASSIGNED TO LIE
04/27/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/25/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/25/2010
ALIE
ASSIGNED TO LIE
03/25/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/22/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/27/2009
GNRT
NON-FINAL ACTION E-MAILED
09/27/2009
CNRT
NON-FINAL ACTION WRITTEN
09/27/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/05/2009
GNRT
NON-FINAL ACTION E-MAILED
03/05/2009
CNRT
NON-FINAL ACTION WRITTEN
03/05/2009
DOCK
ASSIGNED TO EXAMINER
02/27/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/18/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/18/2009
MPMK
NOTICE OF PSEUDO MARK MAILED
12/05/2008
NWAP
NEW APPLICATION ENTERED
12/04/2008
Continuous trademark protection
Get notified about every new filing that threatens EYEGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.